Open AccessActinomycotic Osteomyelitis of the Maxilla in a Patient on Phenytoin
Author(s) -
Farzaneh AghaHosseini,
Elaheh Ghasemzadeh Hoseini,
Nazanin Mahdavi
Publication year - 2022
Publication title -
frontiers in dentistry
Language(s) - English
Resource type - Journals
ISSN - 2676-296X
DOI - 10.18502/fid.v19i3.8511
Subject(s) - osteomyelitis , maxilla , actinomycosis , actinomyces , medicine , phenytoin , mandible (arthropod mouthpart) , dentistry , surgery , biology , epilepsy , botany , psychiatry , bacteria , genetics , genus
Actinomycosis is caused by Actinomyces species and is relatively rare in humans. Because of the special collateral blood flow, osteomyelitis is less common in the maxilla than the mandible. Although there are few case reports for jaw osteomyelitis, actinomycotic osteomyelitis associated with phenytoin therapy has not been reported before. The data show that antiepileptic drugs induce suppression of the immune system. This report presents a rare case of a 58-year-old man on phenytoin with actinomycotic osteomyelitis, and reviews the relevant literature.